CATALOGO DEI PRODOTTI DELLA RICERCA

AMBROSETTI, Achille
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.602
EU - Europa 9.867
AS - Asia 6.636
SA - Sud America 843
AF - Africa 175
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 28.181
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.447
RU - Federazione Russa 2.988
SG - Singapore 2.691
GB - Regno Unito 2.649
CN - Cina 2.123
IT - Italia 954
DE - Germania 775
BR - Brasile 680
SE - Svezia 620
VN - Vietnam 545
FR - Francia 534
HK - Hong Kong 479
FI - Finlandia 442
IE - Irlanda 418
KR - Corea 203
UA - Ucraina 167
IN - India 121
CA - Canada 79
TR - Turchia 76
AR - Argentina 67
BD - Bangladesh 60
ID - Indonesia 50
JP - Giappone 48
AU - Australia 44
NG - Nigeria 44
BE - Belgio 41
MX - Messico 40
NL - Olanda 40
PL - Polonia 40
ES - Italia 38
ZA - Sudafrica 36
IQ - Iraq 31
IR - Iran 31
PK - Pakistan 26
CZ - Repubblica Ceca 24
EC - Ecuador 23
AT - Austria 21
SA - Arabia Saudita 20
VE - Venezuela 19
CO - Colombia 17
UZ - Uzbekistan 17
RO - Romania 16
MA - Marocco 15
EG - Egitto 13
GR - Grecia 13
CL - Cile 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
LT - Lituania 11
NP - Nepal 11
AZ - Azerbaigian 10
MY - Malesia 10
PY - Paraguay 10
TN - Tunisia 10
ET - Etiopia 9
EU - Europa 9
PE - Perù 9
LV - Lettonia 8
PH - Filippine 8
TH - Thailandia 8
CH - Svizzera 7
DK - Danimarca 7
GH - Ghana 7
PT - Portogallo 7
SY - Repubblica araba siriana 7
AL - Albania 6
BG - Bulgaria 6
KZ - Kazakistan 6
PA - Panama 6
CG - Congo 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
JO - Giordania 5
KE - Kenya 5
LK - Sri Lanka 5
NO - Norvegia 5
SI - Slovenia 5
CR - Costa Rica 4
HU - Ungheria 4
LB - Libano 4
NI - Nicaragua 4
OM - Oman 4
PS - Palestinian Territory 4
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
CM - Camerun 3
EE - Estonia 3
HN - Honduras 3
KG - Kirghizistan 3
LU - Lussemburgo 3
MD - Moldavia 3
SN - Senegal 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
GE - Georgia 2
Totale 28.142
Salva come PNG Salva come JPEG
Città #
Southend 2.234
Singapore 1.444
Jacksonville 1.283
Ashburn 1.096
Chandler 1.029
Moscow 918
Woodbridge 823
Dallas 789
San Jose 764
Ann Arbor 540
Hong Kong 473
Dublin 417
Houston 366
The Dalles 310
Beijing 299
Verona 244
Wilmington 215
Los Angeles 207
Jinan 193
Lawrence 179
Princeton 179
Buffalo 175
Ho Chi Minh City 169
Nanjing 165
New York 160
Shenyang 156
Hanoi 118
Hebei 102
Boardman 100
Helsinki 100
Tianjin 80
São Paulo 75
Columbus 74
Milan 70
Sindelfingen 70
Zhengzhou 68
Munich 66
Council Bluffs 63
Hangzhou 58
Changsha 57
Santa Clara 57
Seattle 57
Haikou 56
Taizhou 55
Nanchang 54
Orem 50
Jiaxing 49
Guangzhou 48
Philadelphia 47
Dong Ket 45
Ningbo 45
Rome 43
Falls Church 41
Abuja 39
Fairfield 39
Frankfurt am Main 39
Tokyo 39
Brussels 38
Turku 37
Cambridge 35
Montreal 35
Jakarta 34
Redondo Beach 34
Taiyuan 31
Norwalk 30
London 29
Warsaw 29
Chennai 28
Lanzhou 28
Seoul 28
Brooklyn 27
Fuzhou 25
Haiphong 25
Lancaster 25
Dearborn 24
Perth 24
Toronto 24
Atlanta 22
Bologna 22
Redwood City 22
Stockholm 22
Redmond 21
Rio de Janeiro 21
Manchester 20
Phoenix 20
Washington 20
Belo Horizonte 19
San Francisco 19
Johannesburg 18
Auburn Hills 16
Denver 16
Provo 16
Tashkent 16
Brno 15
Chicago 15
Dhaka 15
Düsseldorf 15
Mumbai 14
Amsterdam 13
Boston 13
Totale 17.731
Salva come PNG Salva come JPEG
Nome #
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 439
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 293
Linfomi del tessuto linfatico associato alle mucose (MALT) delle ghiandole salivari. Descrizione di un caso in un paziente con infezione da virus C dell'epatite e revisione della letteratura 281
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 247
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 246
Acute leukemia and pregnancy. Case report 244
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 243
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 243
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 241
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency 237
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 236
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 235
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 230
An assessment of chimeric transcript detection in CML patients after bone marrow transplantation 229
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 223
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 223
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia 219
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 219
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 218
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 215
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 213
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases] 212
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 212
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 211
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 209
[Clinical and pathological staging of 85 patients with Hodgkin's disease: a clinical contribution (author's transl)] 208
Anemie iporigenerative ipercromiche e macrocitiche 206
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 205
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 204
Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML 203
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C? 202
[Liver and spleen involvement in Hodgkin's disease: critical evaluation of diagnostic procedures (author's transl)] 200
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 200
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 200
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 199
An unusual case of acute leukaemia 199
Folic acid binding protein in chronic granulocytic leukaemia: the effect of methotrexate 196
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 196
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 196
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 196
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma [see comments] 195
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 194
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 191
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 191
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 188
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 187
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 187
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 187
Bone marrow transplantation monitoring by DNA analysis 186
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 185
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 184
CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases 184
Leucemie 183
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 182
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy 181
CT IMAGING OF PRIMARY PANCREATIC LYMPHOMA 181
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia 180
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 179
OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV 177
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 176
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction 174
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia 174
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. 173
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 173
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases 171
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 171
Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis 170
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice 170
Terminal transferase expression in relapsed acute myeloid leukaemia 169
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma 168
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 168
Unicentric Castleman's lymphadenopathy presenting with Behcet's syndrome: a case report 167
the International Extranodal Lymphoma Study group (IELSG). Intravascular lymphoma: clinical presentation, natural history, management, and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”. 166
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. 166
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. 165
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 165
Molecular “warning” CML patients: a retrospective study of Gruppo Triveneto LMC. 164
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 163
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease 162
Regulation of the proliferative potential of cord blood long term culture initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement 162
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 162
Mycobacterial infections preceding hairy-cell leukemia diagnosis. Description of two cases 161
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 161
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 161
BCR breakpoint subregions and blast crisis lineage in CML patients 161
Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions 160
Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: report of the Third Workshop of the Molecular Biology/BMT Study Group 160
Real-life comparison of dasatinib and nilotinib as second-line therapy after imatinib failure for chronic phase CML 159
Valutazione del significato della cupremia come indice di attività e come segno precoce di ricaduta nel cancro della mammella e nel morbo di Hodgkin (studio su 270 Casi). 158
Serum levels of soluble CD30 improve international prognostic score in predicting the outcome of advanced Hodgkin's lymphoma 157
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 156
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 155
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 153
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients 152
Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia 151
Pilot study of survival of patients with chronic myeloid leukemia after determination of intracellular folate binding protein (FABP) 149
Patterns of outcome and prognostic factors in primary large cell lymphoma of the testis in a survey of 373 patients by the International Extranodal Lymphoma Study Grfoup (IELSG). 149
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience 149
Remission of severe antiphospholipid syndrome associated with non Hodgkin's B-cell lymphoma after combined treatment with Rituximab and chemotherapy 149
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 148
Totale 19.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.487
article - articoli 67.409
book - libri 0
conference - conferenze 13.281
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.797
Totale 166.974
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021430 0 0 0 0 0 0 0 0 0 25 265 140
2021/20221.494 144 426 15 113 86 45 33 92 59 39 134 308
2022/20232.990 229 282 292 549 311 705 47 155 314 25 62 19
2023/20241.441 69 143 131 176 157 202 59 104 17 73 196 114
2024/20253.758 265 228 119 623 242 146 186 181 579 194 294 701
2025/20269.816 755 604 862 1.493 2.383 664 1.064 556 793 642 0 0
Totale 28.362